National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
NCI Drug Dictionary
Page Options
Print This Page
More NCI Dictionaries
Dictionary of Cancer Terms

Glossary of Statistical Terms

NCI Dictionary of Genetics Terms

Terminology Resources
Quit Smoking Today
Search for
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All

fluorine F 18 RGD-based integrin peptide-polymer AH111585
A small synthetic peptide containing an RGD-sequence (Arg-Gly-Asp) attached to the positron-emitting isotope fluorine F 18 that may be used to selectively image tumor cells and tumor vasculature by PET imaging. The RGD motif of fluorine F 18 RGD-based integrin peptide-polymer AH111585 selectively binds to the alphaVbeta3 integrin receptor, commonly upregulated on the surfaces of tumor cells and tumor vasculature endothelial cells. This agent may be of use in visualizing and quantifying a decrease in tumor vascularity in response to antiangiogenic agents. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)

Abbreviation:18F-AH111585



Previous:fludrocortisone acetate, FluMist, fluorine F 18 EF5, fluorine F 18 FEQA, fluorine F 18 fluoroethylcholine
Next:fluorine F 18 sodium fluoride, Fluorofur, Fluoroplex, fluorouracil, fluorouracil-e therapeutic implant

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov